Primary Care Medicine: Office Evaluation and Management of the Adult Patient
Book Details
Author(s)Allan H. Goroll, Albert G. Mulley
PublisherLippincott Williams and Wilkins
ISBN / ASIN1451151497
ISBN-139781451151497
AvailabilityExpédition sous 1 à 2 jours ouvrés
Sales Rank99,999,999
MarketplaceFrance 🇫🇷
Description
Clinicians and students at all levels and in all primary care disciplines will benefit from the clear, practical, evidence-based writing and recommendations that address the full spectrum of clinical problems encountered in the adult primary care practice. Whether it's the answer to a screening, prevention, evaluation, or management question or a comprehensive approach to a complex condition, the reader will find a review of best evidence integrated with considerations of affordability, cost-effectiveness, convenience and patient preference. Chapters present actionable, scientifically validated guidance that allows physicians to go beyond standard consensus guidelines and provide highly personalized care. Special consideration is given to team-based approaches of primary care delivery, recognizing its increasing importance to achieving high levels of practice performance. Primary Care Medicine's digital format and quarterly updates ensure current, point-of-care decision support. New, online resources include a recommended curriculum for trainees and faculty, emphasizing a core knowledge base needed for all members of the primary care team, and access to state-of-the-art, condition-specific decision grids to facilitate patient participation in shared decision-making. Features: interactive eBook with searchable text with quarterly updates integrating important new evidence; and unique problem-based chapter organization covers the spectrum of adult primary care, including expanded sections on complementary and alternative therapies, men's and women's health issues, ADHD, posttraumatic stress disorder, and biologic therapies for cancer and autoimmune disorders. All chapters are completely updated with new data from nearly 3000 of the latest and best randomized trials, systematic reviews, meta-analyses, and cost-effectiveness studies, addressing such issues as revised treatment goals for diabetes, hypertension, and hypercholesterolemia; new oral anticoagulants for stroke
